A randomized study of ribavirin plus interferon alfa vs interferon alfa alone for treatment of patients with chronic hepatitis C

被引：0
作者：
Lay, CS [1 ]
Tsai, YL [1 ]
机构：
[1] Mil Taichung Gen Hosp, Taichung, Taiwan
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1842
引用
收藏
页码：621A / 621A
页数：1
相关论文
共 50 条
[31]   PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C [J].
Müller, T .
MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) :1192-1192
[32]   Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C [J].
de Lédinghen, V ;
Trimoulet, P ;
Winnock, M ;
Foucher, J ;
Bourlière, M ;
Desmorat, H ;
Canva, V ;
Capron, D ;
Lévy, S ;
Mion, F ;
Mannant, PR ;
Chêne, G ;
Fleury, H ;
Couzigou, P ;
Bernard, PH .
JOURNAL OF HEPATOLOGY, 2002, 36 (05) :672-680
[33]   Pegylated Interferon Alfa-2a Plus Ribavirin in Chronic Hepatitis C Patients with Genotype 6 [J].
Pham, Thuy T. ;
Ho, Dat T. .
GASTROENTEROLOGY, 2009, 136 (05) :A840-A840
[34]   Combination therapy with interferon alfa and ribavirin as retreatment of interferon relapse in chronic hepatitis C [J].
Davis, GL .
SEMINARS IN LIVER DISEASE, 1999, 19 :49-55
[35]   Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy [J].
Lo Iacono, O ;
Castro, A ;
Diago, M ;
Moreno, JA ;
Fernandez-Bermejo, M ;
Vega, P ;
García, V ;
Carbonell, P ;
Sanz, P ;
Borque, MJ ;
García-Buey, L ;
García-Monzón, C ;
Pedreira, J ;
Moreno-Otero, R .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) :463-469
[36]   Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C [J].
Willson, RA .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (01) :89-92
[37]   Combination of ribavirin and interferon-alfa surpasses high doses of interferon-alfa alone in patients with genotype-1b-related chronic hepatitis C [J].
Pol, S ;
Nalpas, B ;
Bourlière, M ;
Couzigou, P ;
Tran, A ;
Abergel, A ;
Zarski, JP ;
Berthelot, P ;
Bréchot, C .
HEPATOLOGY, 2000, 31 (06) :1338-1344
[38]   Daily or three times a week interferon alfa2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C, final results of a randomized prospective study [J].
de Ledinghen, V ;
Trimoulet, P ;
Winnock, M ;
Foucher, J ;
Chene, G ;
Couzigou, P ;
Bernard, P .
JOURNAL OF HEPATOLOGY, 2001, 34 :138-138
[39]   Lymphoblastoid interferon alfa treatment in chronic hepatitis C [J].
Iorio, R ;
Pensati, P ;
Porzio, S ;
Fariello, I ;
Guida, S ;
Vegnente, A .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (02) :152-156
[40]   Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin [J].
Kerl, K ;
Negro, F ;
Lübbe, J .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (03) :656-656
12345